Neurocrine Stock (NBIX)
Track Neurocrine stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
NBIX
Neurocrine
healthcare
$150.94
â–² +9.58 (+6.82%) past year
Market Cap
$15.98B
P/E Ratio
21.3x
1Y Return
+6.82%
EPS (TTM)
$6.83
Read the latest TheStreet Pro articles mentioning Neurocrine, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
16 articlesDaily Diary Mentions
0 mentionsNo diary mentions for NBIX yet.




